Myocardial oxygenation and high-energy phosphate levels during K ATPchannel blockade

Jianyi Zhang, Arthur H.L. From, Kamil Ugurbil, Robert J. Bache

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Inhibition of ATP-sensitive K+ (KATP) channel activity has previously been demonstrated to result in coronary vasoconstriction with decreased myocardial blood flow and loss of phosphocreatine (PCr). This study was performed to determine whether the high-energy phosphate abnormality during KATP channel blockade can be ascribed to oxygen insufficiency. Myocardial blood flow and oxygen extraction were measured in open-chest dogs during KATP channel blockade with intracoronary glibenclamide, whereas high-energy phosphates were examined with 31P magnetic resonance spectroscopy (MRS), and myocardial deoxymyoglobin (Mb-δ) was determined with 1H MRS. Glibenclamide resulted in a 20 ± 8% decrease of myocardial blood flow that was associated with a loss of phosphocreatine (PCr) and accumulation of inorganic phosphate. Mb-δ was undetectable during basal conditions but increased to 58 ± 5% of total myoglobin during glibenclamide administration. This degree of myoglobin desaturation during glibenclamide was far greater than we previously observed during a similar reduction of blood flow produced by a coronary stenosis (22% of myoglobin deoxygenated during stenosis). The findings suggest that reduction of coronary blood flow with an arterial stenosis was associated with a decrease of myocardial energy demands and that this response to hypoperfusion was inhibited by KATP channel blockade.

Original languageEnglish (US)
Pages (from-to)H1420-H1427
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Issue number4 54-4
StatePublished - Oct 1 2003


  • Blood flow
  • Myoglobin
  • Oxygen saturation


Dive into the research topics of 'Myocardial oxygenation and high-energy phosphate levels during K <sub>ATP</sub>channel blockade'. Together they form a unique fingerprint.

Cite this